7600 — Japan Medical Dynamic Marketing Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual income statement for Japan Medical Dynamic Marketing, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	16,738	19,193	21,308	23,178	25,114
Cost of Revenue
Gross Profit	11,418	12,989	13,993	14,762	15,647
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,660	16,373	19,557	21,637	25,389
Operating Profit	2,078	2,820	1,751	1,541	-275
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,034	2,750	1,770	1,637	-342
Provision for Income Taxes
Net Income After Taxes	1,681	2,142	1,436	1,305	-469
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,665	2,136	1,424	1,272	-462
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,665	2,136	1,424	1,272	-462
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	65.9	76.3	62.5	54.6	27.7
Dividends per Share